June 22, 2018
Joint Commission seeking comments on anticoagulation NPSG
Editor's Note
The Joint Commission announced on June 20 that it is seeking comments on proposed changes to the National Patient Safety Goal (NPSG) 03.05.01 on reducing harm from anticoagulant therapy.
Revised requirements, which will address the use of new direct oral anticoagulant medications, include:
- drug selection
- dosing and monitoring
- bleeding reversal
- perioperative management
- adverse drug events.
Comments will be accepted through July 31, 2018.
Free Daily News
- Study: Excessive overtime, agency nurse staffing harm patients
- Commentary: Technology no substitute for cadaver-based medical education
- Study: Early-stage breast cancer surgery may not be necessary after chemo, radiation
- Experimental brain implant translates thoughts to speech
- Nurses deem flexible, transparent scheduling key to satisfaction, retention
- OR Manager 2025 Career/Salary Survey offers opportunities to learn, give back
- The Joint Commission revises volume criteria for cardiac, stroke certifications
- Pulse oximetry monitoring at home found to save lives of high-risk opioid surgery patients
- New data suggest same-day discharge is safe for joint replacement patients with atrial fibrillation
- FBI investigates as Oracle health data breach exposes patient information
© Access Intelligence, LLC. All rights reserved. |
Privacy Policy |
Cookie Settings |
Diversity, Equity, Inclusion & Belonging |
Accessibility Statement